Clinical Trials Logo

Clinical Trial Summary

Prospective study of both maternal and fetal outcomes of those pregnancies that were complicated by COVID-19 infection at various gestational ages. The follow up will be from the time the diagnosis was made till discharge of the mother and her baby from the hospital.


Clinical Trial Description

Pregnancies that have a confirmed covid-19 infection by nasopharyngeal swab whether taken at our laboratory or confirmed at private or Ministry of health (MOH) laboratories will be followed up till delivery and discharge from the hospital. They will be followed up for hospitalization, intensive care unit (ICU) admission, any complications (organ failure, DIC, renal failure, septic shock), intubation, mortality, miscarriage, congenital malformations, intra-uterine growth restriction (IUGR), oligohydramnios, spontaneous preterm birth, mode of delivery, birth weight, APGAR score at 1 and 5 minutes, neonatal infection with covid-19, neonatal ICU admission and breast feeding. Those patients will be followed up prospectively at our hospital and those with missed follow up and delivered outside our unit will be contacted to bring all the above-mentioned parameters. There will be no exclusion of cases. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04869202
Study type Observational
Source University of Jordan
Contact
Status Completed
Phase
Start date December 1, 2020
Completion date January 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT01487980 - Effect of Delayed Cord Clamping on Haematological Status in Low Birth Weight Infants N/A